KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Inventory (2016 - 2025)

Historic Inventory for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $6.4 billion.

  • Merck's Inventory rose 320.31% to $6.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year increase of 320.31%. This contributed to the annual value of $6.1 billion for FY2024, which is 391.63% down from last year.
  • Latest data reveals that Merck reported Inventory of $6.4 billion as of Q3 2025, which was up 320.31% from $6.6 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Inventory ranged from a high of $6.6 billion in Q2 2025 and a low of $5.5 billion during Q2 2021
  • For the 5-year period, Merck's Inventory averaged around $6.1 billion, with its median value being $6.1 billion (2024).
  • In the last 5 years, Merck's Inventory crashed by 980.94% in 2022 and then skyrocketed by 1103.53% in 2024.
  • Over the past 5 years, Merck's Inventory (Quarter) stood at $6.0 billion in 2021, then fell by 0.71% to $5.9 billion in 2022, then grew by 7.56% to $6.4 billion in 2023, then fell by 3.92% to $6.1 billion in 2024, then increased by 5.48% to $6.4 billion in 2025.
  • Its last three reported values are $6.4 billion in Q3 2025, $6.6 billion for Q2 2025, and $6.2 billion during Q1 2025.